What we achieved in 2025, together
Date
Research news
Date
The study builds on the results from the pioneering Parkinson’s UK funded trial launched in 2019.
Date
A global collaboration of researchers has found a specific gene change is a risk factor for Parkinson’s unique to the Black African community.
Date
The new test can detect problems with mitochondria in blood cells and could one day be used to diagnose Parkinson’s.
Date
A study in people with Parkinson’s suggests the stem cell based treatment is safe and improves symptoms of the condition.
Date
Researchers compared medical records of over 92,000 people in the US with Parkinson’s, other neurological conditions and those without any, to show certain gut conditions increase the risk of Parkinson’s.
Date
Largest study on retinal imaging in Parkinson’s identifies markers of Parkinson’s in eye scans with the help of artificial intelligence (AI).
Date
The AI examined images of brain cells and was able to identify changes in key areas of the cell that are characteristic of the different known mechanisms that cause Parkinson’s.
Date
Updated trial results show NLX-112 could treat motor symptoms as well as dyskinesia. If further trials are successful, we could have a valuable new Parkinson’s drug by 2030.
Date
Results from a UK phase 2 clinical trial show that ursodeoxycholic acid (UDCA) is safe for people with Parkinson's and can increase energy production in cells in the brain.
Date
More research needed to investigate the impact of pesticides on brain cells in Parkinson’s